» Authors » Masahiro Nishibori

Masahiro Nishibori

Explore the profile of Masahiro Nishibori including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 223
Citations 3288
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hisaoka-Nakashima K, Takeuchi Y, Saito Y, Shimoda T, Nakamura Y, Wang D, et al.
Neuroscience . 2024 Sep; 560:56-66. PMID: 39304023
Stress, a risk factor for major depressive disorder and Alzheimer disease, leads to the release of high-mobility group box-1 (HMGB1) protein, which in turn causes neuroinflammation. The mechanism underlying stress-induced...
2.
Gao S, Wang D, Liu K, Tomono Y, Fu L, Gao Y, et al.
Int J Mol Sci . 2024 Jun; 25(11). PMID: 38892076
Epidural and subdural hematomas are commonly associated with traumatic brain injury. While surgical removal is the primary intervention for these hematomas, it is also critical to prevent and reduce complications...
3.
Nishibori M, Wake H, Sakaguchi M
Nihon Yakurigaku Zasshi . 2024 Mar; 159(2):107-111. PMID: 38432918
Acute phase proteins such as CRP, amyloid protein A, and α1-antitrypsin are produced in the liver and their plasma levels are increased during the acute inflammatory response. In contrast, there...
4.
Ma S, Nakamura Y, Kochi T, Uemoto S, Hisaoka-Nakashima K, Wang D, et al.
Biol Pharm Bull . 2024 Jan; 47(1):221-226. PMID: 38246608
Post-traumatic trigeminal neuropathy (PTTN) is a type of chronic pain caused by damage to the trigeminal nerve. A previous study reported that pretreatment with anti-high mobility group box-1 (HMGB1) neutralizing...
5.
Watanabe M, Toyomura T, Wake H, Nishinaka T, Hatipoglu O, Takahashi H, et al.
Biotechnol Appl Biochem . 2023 Nov; 71(2):264-271. PMID: 38010900
We previously found that ribosomal protein L9 (RPL9) is a novel advanced glycation end product (AGE)-binding protein that can decrease pro-inflammatory TNF-α expression stimulated by lipopolysaccharide (LPS) plus high-mobility group...
6.
Nishinaka T, Hatipoglu O, Wake H, Watanabe M, Toyomura T, Mori S, et al.
Arch Biochem Biophys . 2023 Nov; 750:109808. PMID: 37918647
Advanced glycation end products (AGEs) are a heterogeneous group of compounds that are non-enzymatically produced by reactions between carbonyl compounds and proteins. Many types of AGEs are produced according to...
7.
Murata H, Phoo M, Ochi T, Tomonobu N, Yamamoto K, Kinoshita R, et al.
J Biochem . 2023 Sep; 174(6):533-548. PMID: 37725528
Sterile alpha and Toll/interleukin receptor motif-containing protein 1 (SARM1) is a NAD+ hydrolase that plays a key role in axonal degeneration and neuronal cell death. We reported that c-Jun N-terminal...
8.
Kitaoka S, Tomohiro A, Ukeshima S, Liu K, Wake H, Kimura S, et al.
Cells . 2023 Jul; 12(13). PMID: 37443823
Inflammation has been associated with depression, and innate immune receptors, such as the Toll-like receptor (TLR) 2/4 in the medial prefrontal cortex (mPFC), are crucial for chronic stress-induced depression-related behaviors...
9.
Toyomura T, Watanabe M, Wake H, Nishinaka T, Hatipoglu O, Takahashi H, et al.
Mol Biol Rep . 2023 May; 50(7):5849-5858. PMID: 37227674
Background: Advanced glycation end products (AGEs) are heterogeneous proinflammatory molecules produced by a non-enzymatic glycation reaction between reducing sugars (and their metabolites) and biomolecules with amino groups, such as proteins....
10.
Goyama T, Fujii Y, Muraoka G, Nakatani T, Ousaka D, Imai Y, et al.
Sci Rep . 2023 May; 13(1):8386. PMID: 37225824
The aim of this study was to obtain comprehensive data regarding the hemocompatibility of diamond-like carbon (DLC)-coated expanded polytetrafluoroethylene (ePTFE). DLC increased the hydrophilicity and smoothened the surface and fibrillar...